No Detail Found!

Fasudil protects retinal ganglion cells and promotes axonal regeneration

Author(s)
Jie Zhang Department of Ophthalmology, Shijiazhuang Third Hospital,Shijiazhuang, Hebei,China
Weichao Wang Department of Endocrinology, Shijiazhuang First Hospital,Shijiazhuang, Hebei,China
Hong Wang Department of Geriatrics, Shijiazhuang First Hospital,Shijiazhuang, Hebei,China
Junru Liu Department of Ophthalmology, Shijiazhuang Third Hospital,Shijiazhuang, Hebei,China
Zhihong Zhang Department of Ophthalmology, Shijiazhuang Third Hospital,Shijiazhuang, Hebei,China
Abstract
This study was aimed to investigate whether fasudil can protect retinal ganglion cells and promote axonal regeneration by inhibiting RhoA/Rock pathway. Long Evans rats were used to establish an optic nerve injury model. Apoptosis was detected by TUNEL, and surviving RGCs was detected by Fluoro-Gold retrograde label and hematoxylineosin (HE) staining was used to evaluate pathological changes and western blot was used to measure the expression of protein. After 10 days of optic nerve injury rat model, increased cell apoptosis and decreased FG-positive RGCs in rat eye, but fasudil could reverse these changes. In vitro, fasudil could not only increase the number of RGCs with protuberances, but also increase the length of protuberances. Moreover, fasudil could not only reduce the expression of total-cohoin, Rock, total-cofilin and total-MLC protein induced by optic nerve injury, but also reduce the relative expression of GTP-RhoA, p-cofilin and p-MLC protein. Fasudil protects retinal ganglion cells and promotes axonal regeneration by inhibiting RhoA / Rock pathway.
Publication Details
Page(s) 2431-2437
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: S5, Year: 2020

Request the full text from PASTIC

Keywords
Fasudil, RhoA / Rock pathway, retinal ganglion cells, axonal regeneration
References
Bertrand J,Di PA,Mckerracher L .2007 .Enhanced survival and regeneration of axotomized retinal neurons by repeated delivery of cell-permeable C3-like Rho antagonists. Neurobiol. Dis., 25(1) : 65-72.
Chan SL,Cipolla MJ SL .2017 .Treatment with low dose fasudil for acute ischemic stroke in chronic hypertension. J. Cereb. Blood. Flow. Metab., 37(9) : 3262-3270.
Couch BA,Demarco GJ,Gourley SL,Koleske AJ .2010 .Increased dendrite branching in AbetaPP/PS1 mice and elongation of dendrite arbors by fasudil administration. J. Alzheimers Dis, 20(4) : 1003-1008.
Fehlings MG,Kim KD,Aarabi B .2018 .Rho Inhibitor VX-210 in acute traumatic subaxial cervical spinal cord injury: Design of the spinal cord injury Rho inhibition investigation (SPRING) clinical trial. J. Neurotraum, 35(9) : 1049-1056.
Fehlings Forgione N,MG Forgione N .2014 .Rho-ROCK Inhibition in the treatment of spinal cord injury. , 82(3-4) : e535-e539.
Fu Q,Hue J,Li S J .2007 .Nonsteroidal antiinflammatory drugs promote axon regeneration via RhoA inhibition. J. Neurosci., 27(15) : 4154.
Fujita Y,Yamashita T Y .2014 .Axon growth inhibition by RhoA/ROCK in the central nervous system. Front. Neurosci., 8 : 338.
Furuya T,Hashimoto M,Koda M,Okawa A,Murata A,Takahashi K,Yamashita T,Yamazaki M .2009 .Treatment of rat spinal cord injury with a Rho-kinase inhibitor and bone marrow stromal cell transplantation. Brain Res., 1295 : 192-202.
Haring RS,Canner JK,Haider AH,Schneider EB .2016 .Ocular injury in the United States: Emergency department visits from 2006-2011. , 47(1) : 104-108.
Hertz J,Robinson R,Valenzuela D A,Lavik E B.,Goldberg JL E B. .2013 .A tunable synthetic hydrogel system for culture of retinal ganglion cells and amacrine cells. Acta. Biomater, 9(8) : 7622-7629.
Hou Y,Zhou L,Yang QD,Du XP,Li M,Yuan M,Zhou ZW M .2012 .Changes in hippocampal synapses and learning-memory abilities in a streptozotocintreated rat model and intervention by using fasudil hydrochloride. Neuroscience, 200 : 120-129.
Isenmann S,Kretz A,Cellerino A .2003 .Molecular determinants of retinal ganglion cell development, survival, and regeneration. Pro. Retin Eye Res., 22(4) : 483-543.
Ishihara M,Yamanaka K,Yamasaki M K .2012 .Intracranial hemorrhage after intra-arterial administration of fasudil for treatment of cerebral vasospasm following subarachnoid hemorrhage: a serious adverse event. Neuroradiology, 54(1) : 73-75.
Jonathan H,Bo Q,Ying H,Patel RD,Valenzuela DA,Goldberg JL DA .2014 .Survival and integration of developing and progenitor-derived retinal ganglion cells following transplantation. Cell Transplant, 23(7) : 855-872.
Kanazawa Y,Takahashi-Fujigasaki J,Ishizawa S,Takabayashi N,Ishibashi K,Matoba K,Kawanami D,Yokota T,Tajima N,Utsunomiya K .2013 .The Rho-kinase inhibitor fasudil restores normal motor nerve conduction velocity in diabetic rats by assuring the proper localization of adhesion-related molecules in myelinating Schwann cells. Exp. Neurol., 247 : 438-446.
Leaver SG,Cui Q,Bernard O,Harvey A R .2010 .Cooperative effects of bcl-2 and AAV-mediated expression of CNTF on retinal ganglion cell survival and axonal regeneration in adult transgenic mice. Eur. J. Neurosci., 24(12) : 3323-3332.
Li HJ,Sun ZL,Yang XT,Zhu L,Feng DF L .2017 .Exploring Optic Nerve Axon Regeneration. Curr. Neuropharmacol., 15(6) : 861-873.
Li J,Li N,Jiang Y .2015 .Mesenchymal stem cells secrete brain-derived neurotrophic factor and promote retinal ganglion cell survival after traumatic optic neuropathy. J. Craniofac. Surg., 26(2) : 548-552.
Lin X,Ogiya M,Takahara M,Yamaguchi W,Furuyama T,Tanaka H,Tohyama M,Inagaki S M .2007 .Sema4Dplexin-B1 implicated in regulation of dendritic spine density through RhoA/ROCK pathway. , 428(1) : 1-6.
Liu GJ,Wang ZJ,Wang YF,Xu LL,Wang XL,Liu Y,Luo GJ,He GH,Zeng YJ .2012 .Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Eu. J. Clin. Pharmacol, 68(2) : 131-139.
Margolis SS,Salogiannis J,Lipton DM,Mandel-Brehm C,Wills ZP,Mardinly AR,Hu L,Greer PL,Bikoff JB,Ho HY .2016 .EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell, 143(3) : 442-455.
Ming D,Yan BP,Liao JK,Lam YY,Yip G WK,Yu CM .2010 .Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. Drug. Discov. Today, 15 : 622-629.
Nagumo H,Sasaki Y,Ono Y,Okamoto H,Seto M,Takuwa Y,Physiol-Cell Ph Y .2000 .Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am. J, 278(1) : C57-C65.
Nishio Y,Koda M,Kitajo K,Seto M,Hata K,Taniguchi J,Moriya H,Fujitani M,Kubo T,Yamashita T .2006 .Delayed treatment with Rho-kinase inhibitor does not enhance axonal regeneration or functional recovery after spinal cord injury in rats. Exp. Neurol., 200(2) : 392-397.
Ridley A.J. .2012 .Rho GTPases. Methods in Molecular Biology (Methods and Protocols), 827(1) : 1.
Sadok A,Marshall CJ .2014 .Rho GTPases. Small Gtpases, 5(4) : e983878.
Sanjari N,Pakravan M,Nourinia R,Esfandiari H,HafeziMoghadam A,Zandi S,Nakao S,Shah-Heidari MH,Jamali A,Yaseri M .2016 .Intravitreal injection of a Rho-kinase inhibitor (Fasudil) for recent-onset nonarteritic anterior ischemic optic neuropathy. J. Clin. Pharmacol, 56(6) : 749-753.
Wei Shi J,L Shi J .2007 .Rho kinase in the regulation of cell death and survival. Arch. Immunol Ther, 55(2) : 61-75.
Shimokawa H,Sunamura S,Satoh K S .2016 .RhoA/Rho-Kinase in the cardiovascular system. Circ. Res., 118(2) : 352-366.
Sung JK,Miao L,Calvert JW,Huang L,Harkey HL,Zhang JH .2003 .A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. Brain Res., 959(1) : 29-38.
Takekazu K,Atsushi Y,Nobuyoshi I,Toshihide Y .2008 .The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther. Clin. Risk Manag., 4(3) : 605-615.
Tetsuya S,Maho S,Sumiko K,Takashi O,Masahiro T,Hidehiro O,Tsunehiko I .2011 .Effects of fasudil, a Rho-associated protein kinase inhibitor, on optic nerve head blood flow in rabbits. Invest. Ophth. Vis. Sci., 52(1) : 64-69.
Thomas CN,Berry M,Logan A,Blanch RJ,Ahmed Z RJ .2017 .Caspases in retinal ganglion cell death and axon regeneration. Cell Death Discov., 3 : 17032.
Vidalsanz M,Galindoromero C,Valientesoriano FJ,Nadalnicolás FM,Ortinmartinez A,Rovere G,Salinasnavarro M,Lucasruiz F,Sanchezmigallon MC,Sobradocalvo P .2017 .Shared and differential retinal responses against optic nerve injury and ocular hypertension. Front. Neurosci., 11 : 1-14.
Wang H,Zhang C,Lu D,Shu X,Zhu L,Qi R,So KF,Lu D,Xu Y .2013 .Oligomeric proanthocyanidin protects retinal ganglion cells against oxidative stressinduced apoptosis. Neural Regen. Res., 8(25) : 2317-2326.
Wang YH,Wang Y,Liu Y,Wang SJ,Zeng YX .2004 .Culture and identification of retinal ganglion cells in Long Evans rats. Di-San Junyi Daxue Xuebao, 26(5) : 412-415.
Wu S,Chang KC,Nahmou M,Goldberg JL M .2018 .Induced pluripotent stem cells promote retinal ganglion cell survival after transplant. Invest Ophthalmol. Vis. Sci., 59(3) : 1571-1576.
Yamashita K,Kotani Y,Nakajima Y,Shimazawa M,Yoshimura SI,Nakashima S,Iwama T,Hara H T .2007 .Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons. Brain Res., 1154 : 215-224.
You Y,Gupta VK,Li JC,Klistorner A,Graham SL .2013 .Optic neuropathies: Characteristic features and mechanisms of retinal ganglion cell loss. Rev. Neurosci., 24(3) : 301-321.
0

Citations

0

Downloads

10

Views